Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Assets Average (2016 - 2025)

Historic Assets Average for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $6.5 million.

  • Silo Pharma's Assets Average fell 2148.63% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 2148.63%. This contributed to the annual value of $7.6 million for FY2024, which is 2182.18% down from last year.
  • According to the latest figures from Q3 2025, Silo Pharma's Assets Average is $6.5 million, which was down 2148.63% from $6.3 million recorded in Q2 2025.
  • Silo Pharma's 5-year Assets Average high stood at $12.3 million for Q4 2022, and its period low was $3.5 million during Q1 2021.
  • For the 5-year period, Silo Pharma's Assets Average averaged around $8.5 million, with its median value being $8.3 million (2024).
  • Per our database at Business Quant, Silo Pharma's Assets Average soared by 67176.61% in 2021 and then crashed by 3520.26% in 2024.
  • Quarter analysis of 5 years shows Silo Pharma's Assets Average stood at $10.9 million in 2021, then increased by 12.85% to $12.3 million in 2022, then tumbled by 32.23% to $8.4 million in 2023, then fell by 4.51% to $8.0 million in 2024, then decreased by 18.41% to $6.5 million in 2025.
  • Its Assets Average was $6.5 million in Q3 2025, compared to $6.3 million in Q2 2025 and $6.7 million in Q1 2025.